Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,382,126
+$4,543,267 QoQ
Shares Held
287,019
+66.9% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 290 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,124 across 425 Biotechnology names. DNLI ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in DNLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,382,126 | 287,019 | Shares | Other | 2026-08-12 | |
| 2025-12-31 | $2,838,859 | 171,948 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,541,303 | 175,021 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,680,663 | 191,613 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $2,561,336 | 188,403 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $4,544,389 | 222,983 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $6,856,791 | 235,386 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $5,133,056 | 221,062 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,851,047 | 138,940 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $3,933,958 | 183,316 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $3,465,094 | 167,964 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $4,662,342 | 157,992 | Shares | Other | 2023-08-11 | |
| 2022-12-31 | $5,116,369 | 183,976 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,325,383 | 108,354 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,943,733 | 100,025 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,132,455 | 97,372 | Shares | Defined | 2022-05-11 | |
| 2021-09-30 | $4,969,828 | 98,510 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,128,626 | 90,880 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,292,835 | 75,181 | Shares | Defined | 2021-05-12 | |
| 2020-09-30 | $11,066,238 | 308,854 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,916,506 | 244,686 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,079,009 | 175,843 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||